A call to action has been issued for clinicians and US guidelines committees to reevaluate the utility of DPYD testing before administering fluoropyrimidine (FP) chemotherapy, but not everyone agrees.
A group of volunteer oncologists, pathologists, and other specialists, some of whom are retired, are offering a service where they give an expert second opinion to patients with cancer at no charge.